Tissue Regenix commercializes innovative technologies in regenerative medicine.
Tissue Regenix has raised €17M across 1 funding round, most recently a round in May 2020. Based in York, UK; founded 2006; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-22 | Other | €17M |
| — |
| View deal → |
